CFDE Data Portal | Search MIR4453HG

	Label	Description
	MIR4453HG Gene (Entity type)	ENSG00000268471 - MIR4453 host gene
	GSE102505 tunicamycin 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE188728 GSE188730 BRG1 HSA BCL7 knockdown B cell 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236896 GSE237665 DNMT EZH2 inhibition 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178267 vemurafenib 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR4453HG

ENSG00000268471 - MIR4453 host gene

GSE102505 tunicamycin 6 v 2 human up

A Gene Set from LINCS

GSE188728 GSE188730 BRG1 HSA BCL7 knockdown B cell 0 v 1 human dn

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 1 human dn

A Gene Set from LINCS

GSE236896 GSE237665 DNMT EZH2 inhibition 6 v 0 human up

A Gene Set from LINCS

GSE159678 hydroxychloroquine 6 v 3 human up

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

A Gene Set from LINCS

GSE178267 vemurafenib 2 v 0 human up

A Gene Set from LINCS

GSE173201 cisplatin 2 v 1 human up

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.